tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
13Bullish
4Neutral
5Bearish
Oscillators
Neutral
3Bullish
4Neutral
3Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
2Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.27, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 19.89, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 19.43, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Jul 20, 2025, 07:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.48
20.48
20.48
20.48
20.48
20.48
20.48
Fibonacci
20.48
20.48
20.48
20.48
20.48
20.48
20.48

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Jul 20, 2025, 07:16 PM
Period
Simple
Exponential
MA5
20.21Sell
20.22Sell
MA10
20.11Buy
20.10Buy
MA20
19.81Buy
19.89Buy
MA50
19.37Buy
19.43Buy
MA100
18.83Buy
19.20Buy
MA200
19.30Buy
19.38Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 20.10, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 19.20, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 19.37, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 18.83, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.30, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Jul 20, 2025, 07:16 PM
Name
Value
Action
RSI (14)
59.87
Neutral
STOCH (9,6)
82.97
Sell
STOCHRSI (14)
89.70
Sell
MACD (12,26)
0.27
Sell
ADX (14)
23.19
Neutral
Williams %R
-30.76
Buy
CCI (14)
81.01
Neutral
ATR (14)
0.16
-
Ultimate Oscillator
62.16
Neutral
ROC
5.27
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 59.87, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 23.19, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 81.01, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 5.27, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 59.87, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.27, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 20.21, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 19.81, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 19.37, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.30, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -30.76, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 81.01, which suggests CURE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement